Dana-Farber

Join us on Wednesday, May 6, for the Lubin Family Foundation Scholar Award Annual Symposium to network and learn about exciting advancements in cancer care and research led by the most promising physician-scientists across Boston’s academic medical community. The event will also feature Nobel Laureate, William G. Kaelin Jr., MD, the program’s scientific director, and guest speaker, Owen N. Witte, MD. RSVP here: bit.ly/4u6ybYo

@_shiny_side_up_ Congratulations, Gino! 💙👏

Day 127/126 - earning my sixth star at #Boston130 with @DanaFarber

Pancreatic cancer research at #AACR26: Dr. Brian Wolpin of @DanaFarber_Hale presents encouraging data on safety and efficacy from a small study combining the RAS inhibitor daraxonrasib with chemotherapy in patients with advanced #PancreaticCancer. @danafarber ➡️bit.ly/4cAoXMU

Today at #AACR26: Noah Fields, MS, of @DanaFarber’s @VanAllenLab, presents findings from a familial cancer study suggesting that high-resolution germline genetic testing could benefit patients with familial cancer. ➡️ bit.ly/4crIeQl

Today at #AACR26 @zeyun_lu, a research fellow in @SashaGusevPosts’s lab @DanaFarber, presents findings suggesting that large language model-based extraction of unstructured clinical notes can provide scalable and accurate characterization of immune-related side effects and provide insights about prognosis. ➡️ bit.ly/4mxMtyF

Suart H. Orkin, MD, has been honored with the @brkthroughprize in Life Sciences for discovering how the body turns off fetal hemoglobin after birth, a finding that led to a new treatment strategy for sickle cell disease. Learn more: bit.ly/4cvCTHW

At the #AACR26 press conference, @OmarNadeemMD of @DanaFarber presents results of the phase 2 CAR-PRISM clinical trial, the first to investigate CAR T-cell therapy in patients with high-risk smoldering multiple myeloma. The study also published today at @NatureMedicine: bit.ly/3Qpatba

Congratulations once again to @DanaFarber’s Dr. Alice Shaw, Dr. Kimberly Stegmaier and Dr. Matthew Vander Heiden who were elected as Fellows of the @AACR Academy Class of 2026. Read more: bit.ly/4suWu0L

Dr. Alice Shaw @DanaFarber will highlight emerging science shaping the future of global cancer research and clinical care in today’s #AACR26 Opening Plenary. Learn more: bit.ly/3Q9Fy2u

This weekend, our researchers will present more than 50 studies at the American Association for Cancer Research (AACR) Annual Meeting in San Diego. Learn more about our #AACR26 highlights here: bit.ly/41GQR4I

There is no shortage of innovation when it comes to the vision of our future cancer hospital. Benjamin L. Ebert, MD, PhD, sat down with the @BostonGlobe Media to discuss the work behind bringing these ideas into fruition. bostonglobe.com/2026/04/13/bus…

While many physician-scientists have attempted to treat glioblastoma, it remains one of the most difficult human cancer types to manage. Learn more about how researchers are changing the trajectory of brain cancer with a stronger immune defense: bit.ly/3PS3fwa

Nonsmoking Asian American and Latina women have higher rates of lung cancer. Why can’t they get screened? trib.al/phul2xs

A new study published in @nchembio by Mei Ying Ng, PhD, of @DanaFarber’s Chouchani Lab identifies a druggable cysteine redox switch controlling macrophage cytokine responses and provides a compendium of redox-regulated sites for therapeutic development. Read more: bit.ly/47weEI4

.@goldietaylor was recently named to @BeckersHR's 2026 CMOs to Know list. Please join us in congratulating her on this recognition. View the list here: bit.ly/4c40VcV

New research published in @NatMetabolism by @DanaFarber’s Spiegelman Lab reveals that irisin-driven cell-cell and inter-tissue interactions improve obesity & glucose intolerance and increase energy expenditure, with no reduced food intake and muscle loss in obese mice. Read more: bit.ly/4sdGhgf

Ursula A. Matulonis, MD, of @DFCIGynOnc brings expert insights into the most recent breakthroughs, evolving standards, and emerging therapies across gynecologic cancers in her series with @OncLive, From Discovery to Delivery: Charting Progress in Gynecologic Oncology. Watch here: bit.ly/40xFiMu

Magnolia Contreras, vice president of community health, is the recipient of the Massachusetts Public Health Alliance’s Lemuel Shattuck Award for significant contributions to public health practice. Please join us in congratulating her on this recognition. Learn more: bit.ly/4dYYwma

“Telomerase is a core driver of cancer, it’s involved in increased risk of developing cancer, and it influences toxicities from treatments for cancer,” says R. Coleman Lindsley, MD, PhD. His lab is studying how telomere length in blood cells may affect stem cell transplant outcomes in patients with blood cancer. Learn more: bit.ly/4dqYGTo

Welcome home and good luck to our friends, @RedSox! #KCANCER